Related Experiment Video
Updated: Jun 15, 2026

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
Published on: January 7, 2019
Anthrax lethal toxin impairs CD1d-mediated antigen presentation by targeting the extracellular signal-related kinase
Masood A Khan1, Richard M Gallo, Randy R Brutkiewicz
1Department of Microbiology and Immunology, Indiana University School of Medicine, 950 W. Walnut St., Indianapolis, IN 46202-5181, USA.
Abstract:
Lethal toxin (LT) is a critical virulence factor of Bacillus anthracis and an important means by which this bacterium evades the host's immune system. In this study, we demonstrate that CD1d-expressing cells treated with LT have reduced CD1d-mediated antigen presentation. We earlier showed an important role for the mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 (ERK1/2) in the regulation of CD1d-mediated antigen presentation, and we report here that LT impairs antigen presentation by CD1d in an ERK1/2-dependent manner. Similarly, LT and the ERK1/2 pathway-specific inhibitor U0126 caused a decrease in major histocompatibility complex (MHC) class II-mediated antigen presentation. Confocal microscopy analyses revealed altered intracellular distribution of CD1d and LAMP-1 in LT-treated cells, similar to the case for ERK1/2-inhibited cells. These results suggest that Bacillus anthracis has the ability to evade the host's innate immune system by reducing CD1d-mediated antigen presentation through targeting the ERK1/2 pathway.
Insights
Bacillus anthracis lethal toxin impairs immune response by reducing CD1d and MHC class II antigen presentation. This evasion mechanism targets the extracellular signal-regulated kinase 1/2 pathway.
Area of Science:
- Immunology
- Microbiology
- Cell Biology
Background:
- Bacillus anthracis lethal toxin (LT) is a key virulence factor.
- LT facilitates bacterial immune evasion.
- CD1d-mediated antigen presentation is crucial for immune responses.
Purpose of the Study:
- To investigate the effect of LT on CD1d-mediated antigen presentation.
- To determine the role of the ERK1/2 pathway in LT-induced immune modulation.
- To elucidate the mechanism of Bacillus anthracis immune evasion.
Main Methods:
- Treatment of CD1d-expressing cells with LT.
- Assessment of CD1d- and MHC class II-mediated antigen presentation.
- Inhibition of the ERK1/2 pathway using U0126.
- Confocal microscopy to analyze intracellular distribution of CD1d and LAMP-1.
Main Results:
- LT significantly reduced CD1d-mediated antigen presentation.
- LT impaired antigen presentation in an ERK1/2-dependent manner.
- LT and U0126 decreased MHC class II-mediated antigen presentation.
- Altered intracellular distribution of CD1d and LAMP-1 was observed in LT-treated cells.
Conclusions:
- Bacillus anthracis LT evades the host immune system by inhibiting CD1d-mediated antigen presentation.
- The ERK1/2 pathway is a critical target for LT-induced immune evasion.
- LT disrupts normal antigen-presenting cell function, compromising innate immunity.
Related Concept Videos
Inhalation Anthrax
The Extrinsic Apoptotic Pathway
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
MAPK Signaling Cascades
The Intrinsic Apoptotic Pathway
Diphtheria
